| Adam John Miller, PA-C | |
|
215 Brookshire Ln, Beckley, WV 25801-6729 | |
| (304) 253-1077 | |
| (304) 253-9611 |
| Full Name | Adam John Miller |
|---|---|
| Gender | Male |
| Speciality | Physician Assistant |
| Experience | 13 Years |
| Location | 215 Brookshire Ln, Beckley, West Virginia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1386927309 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363AM0700X | Physician Assistant - Medical | (* (Not Available)) | Secondary |
| 363AS0400X | Physician Assistant - Surgical | 01574 (West Virginia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Raleigh General Hospital | Beckley, WV | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| West Virginia Spine Center, Pllc | 9335523968 | 2 |
News Archive
A toxin linked to a targeted monoclonal antibody has shown "compelling" antitumor activity in patients with non-Hodgkin lymphomas who were no longer responding to treatment, according to a report from Dana-Farber Cancer Institute.
A new study produced by an interdisciplinary team led by Prof. Antonio Giordano, director of the Sbarro Institute for Cancer Research and Molecular Medicine at Temple University, tracks the development process and efficacy of the Italian translation of the Derriford Appearance Scale 24, an important clinical tool in identifying quality-of-life issues for breast cancer patients, especially concerns regarding body shame, depression, anxiety, overall appearance and appearance identity.
According to a new sub-analysis from the ACCENT I (A Crohn's disease Clinical trial Evaluating infliximab in a New long-term Treatment regimen) trial patients who received a three-dose induction regimen of Remicade experienced a significantly greater reduction in pain as assessed by four different pain questions after ten weeks, compared with patients who received a single dose of Remicade.
Ear infections caused by more than one species of bacteria could be more persistent and antibiotic-resistant because one pathogen may be communicating with the other, encouraging it to bolster its defenses. Interrupting or removing that communication could be key to curing these infections. Researchers from Wake Forest University Baptist Medical Center publish their findings today in mBio-, the online open-access journal of the American Society for Microbiology.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Adam John Miller, PA-C 215 Brookshire Ln, Beckley, WV 25801-6729 Ph: (304) 253-1077 | Adam John Miller, PA-C 215 Brookshire Ln, Beckley, WV 25801-6729 Ph: (304) 253-1077 |
News Archive
A toxin linked to a targeted monoclonal antibody has shown "compelling" antitumor activity in patients with non-Hodgkin lymphomas who were no longer responding to treatment, according to a report from Dana-Farber Cancer Institute.
A new study produced by an interdisciplinary team led by Prof. Antonio Giordano, director of the Sbarro Institute for Cancer Research and Molecular Medicine at Temple University, tracks the development process and efficacy of the Italian translation of the Derriford Appearance Scale 24, an important clinical tool in identifying quality-of-life issues for breast cancer patients, especially concerns regarding body shame, depression, anxiety, overall appearance and appearance identity.
According to a new sub-analysis from the ACCENT I (A Crohn's disease Clinical trial Evaluating infliximab in a New long-term Treatment regimen) trial patients who received a three-dose induction regimen of Remicade experienced a significantly greater reduction in pain as assessed by four different pain questions after ten weeks, compared with patients who received a single dose of Remicade.
Ear infections caused by more than one species of bacteria could be more persistent and antibiotic-resistant because one pathogen may be communicating with the other, encouraging it to bolster its defenses. Interrupting or removing that communication could be key to curing these infections. Researchers from Wake Forest University Baptist Medical Center publish their findings today in mBio-, the online open-access journal of the American Society for Microbiology.
› Verified 6 days ago
Michael D Mcmillion, PA-C Physician Assistant Medicare: Medicare Enrolled Practice Location: 25 Mallard Ct, Beckley, WV 25801 Phone: 304-255-2527 Fax: 304-255-5675 | |
Kristen Michelle Quinn, PA Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 250 Stanaford Rd Ste 209, Beckley, WV 25801 Phone: 304-255-3520 | |
Ashley Copolo, PA-C Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 200 Veterans Ave, Beckley, WV 25801 Phone: 304-255-2121 | |
Janette A Adkins, PA-C Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 121 George St, Beckley, WV 25801 Phone: 304-250-0382 | |
Shakur Ali Sobhan, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 405 Carriage Dr, Beckley, WV 25801 Phone: 304-250-0226 | |
Mrs. Sherri Jo Lilly, PA Physician Assistant Medicare: May Accept Medicare Assignments Practice Location: 1709 Harper Rd, Beckley, WV 25801 Phone: 304-256-8671 | |
Elizabeth Denise Cooper, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 200 Veterans Ave, Beckley, WV 25801 Phone: 304-255-2121 |